相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract
Frieder Fuchs et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)
Management of candiduria in hospitalized patients: a single-center study on the implementation of IDSA guidelines and factors affecting clinical decisions
Zhengxin He et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)
Antifungal activity of nitroxoline against Candida auris isolates
Frieder Fuchs et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Emergence of resistant Candida glabrata in Germany
Alexander Maximilian Aldejohann et al.
JAC-ANTIMICROBIAL RESISTANCE (2021)
Pharmacokinetics and Pharmacodynamics of Posaconazole
Lu Chen et al.
DRUGS (2020)
Drug Repurposing for the Treatment of Bacterial and Fungal Infections
Andrea Miro-Canturri et al.
FRONTIERS IN MICROBIOLOGY (2019)
Susceptibility of carbapenemase-producing Enterobacterales (CPE) to nitroxoline
Frieder Fuchs et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
In vitro activity of mecillinam and nitroxoline against Neisseria gonorrhoeae - re-purposing old antibiotics in the multi-drug resistance era
Frieder Fuchs et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2019)
Development of High-Level Echinocandin Resistance in a Patient With Recurrent Candida auris Candidemia Secondary to Chronic Candiduria
Mark J. Biagi et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Candida auris in Germany and Previous Exposure to Foreign Healthcare
Axel Hamprecht et al.
EMERGING INFECTIOUS DISEASES (2019)
Nitroxoline in geriatric patients with lower urinary tract infection fails to achieve microbiologic eradication: a noncomparative, prospective observational study
C. Forstner et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Empirical treatment of lower urinary tract infections in the face of spreading multidrug resistance: in vitro study on the effectiveness of nitroxoline
A. Sobke et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline
Rixt A. Wijma et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
Romuald Bellmann et al.
INFECTION (2017)
Nitroxoline: a broad-spectrum biofilm-eradicating agent against pathogenic bacteria
Yasmeen Abouelhassan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Candiduria: Evidence-based approach to management, are we there yet?
W. A. Alfouzan et al.
JOURNAL DE MYCOLOGIE MEDICALE (2017)
The global problem of antifungal resistance: prevalence, mechanisms, and management
David S. Perlin et al.
LANCET INFECTIOUS DISEASES (2017)
Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients. Update 2017 of the interdisciplinary AWMF S3 guideline
J. Kranz et al.
UROLOGE (2017)
Epidemiology, diagnostics, therapy, prevention and management of uncomplicated bacterial outpatient acquired urinary tract infections in adult patients. Update 2017 of the interdisciplinary AWMF S3 guideline
J. Kranz et al.
UROLOGE (2017)
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2016)
Urinary Concentrations and Antibacterial Activities of Nitroxoline at 250 Milligrams versus Trimethoprim at 200 Milligrams against Uropathogens in Healthy Volunteers
Florian M. E. Wagenlehner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In Vitro Activity of Nitroxoline against Escherichia coli Urine Isolates from Outpatient Departments in Germany
Michael Kresken et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Review of the literature and individual patients' data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections
Kurt G. Naber et al.
BMC INFECTIOUS DISEASES (2014)
The Urinary Antibiotic 5-Nitro-8-Hydroxyquinoline (Nitroxoline) Reduces the Formation and Induces the Dispersal of Pseudomonas aeruginosa Biofilms by Chelation of Iron and Zinc
A. Sobke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Candida Urinary Tract Infections-Treatment
John F. Fisher et al.
CLINICAL INFECTIOUS DISEASES (2011)
Is it time to abandon the use of amphotericin B bladder irrigation?
RH Drew et al.
CLINICAL INFECTIOUS DISEASES (2005)
Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate
I Bekersky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
分享论文
